Developer docs
API playgroundTry for free, no card

Search company profiles

Syrma Johari Medtech Limited

Full company profile

uuid00088d2

Namestring
Syrma Johari Medtech Limited
Legal namestring
Syrma Johari MedTech Ltd.
Company typeenum
Private
Founded yearint
1980
Descriptiontext

Syrma Johari Medtech Limited is a privately held, India-headquartered end-to-end MedTech contract development and manufacturing organization (CDMO), founded around 1979–1980, that provides design, engineering, ISO 13485-certified manufacturing, and regulatory compliance services to global medical device OEMs. The company operates 16 production sites and 4 design and innovation centers spanning India, the United States, the European Union, and the United Kingdom, with 2.1 million square feet of total manufacturing space. Its technical platform spans six core technology areas—microfluidics, optics and photonics, radiofrequency, therapeutic ultrasound, electrotherapy, and microneedling—organized around six MedTech verticals: Diagnostics & IVD, Surgical & Interventional Care, Medical Aesthetics, Patient Monitoring, Critical Care, and Rehabilitation & Physical Therapy. Certifications across ISO 13485, MDSAP, FDA, and GMP, combined with integrated QARA capabilities, allow it to take OEM products from concept through scalable, multi-jurisdictional commercial production.

The company monetizes through B2B contract manufacturing fees, design and engineering services, and regulatory and lifecycle support, with quote-based pricing determined by product complexity, volume, and engagement scope. Its go-to-market is enterprise field sales targeting MedTech OEMs globally, supported by direct partnership models and regional manufacturing hubs. Named OEM partners include Hemex Health (point-of-care diagnostics), Volk Optical (endoscopic imaging), Spinex (medical devices), and Intelligent Bio Solutions, the latter representing the largest disclosed engagement: a strategic manufacturing partnership for the Intelligent Fingerprinting Drug Screening Reader that quadruples the customer's prior capacity, delivers more than 40% in annual production cost savings, and supports INBS's planned 2026 US market entry.

The company holds a string of recent industry recognitions—MedTech CDMO of the Year – Diagnostics and IVD (2026), Service Provider of the Year – Medical Supplies at the ET Healthcare Awards (2025), National Export Excellence Award (2024), and ET MSME Awards (2023)—and participates in India's PLI scheme for medical devices. There are no disclosed funding rounds, revenue figures, ownership percentages, or executive hires beyond the CEO, Suhas Tamras, in the available data.

Short descriptiontext

India-based end-to-end MedTech CDMO with 16 production sites and 4 design centers across India, the US, the EU, and the UK, providing ISO 13485-certified design, engineering, manufacturing, and regulatory services to global medical device OEMs across diagnostics, surgical, aesthetics, critical care, patient monitoring, and rehabilitation segments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersJodhpur, India
HQ citystring
Jodhpur
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device manufacturing, contract manufacturing services, medtech design engineering, regulatory compliance services, in vitro diagnostics manufacturing
Industry2 codes
1Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control)
CodeHLAGAKALPrimaryYes
2Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent)
CodeHLAGAKAOPrimaryNo
NAICS code4 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Medical Equipment and Supplies Manufacturing3391
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Scientific Research and Development Services5417
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Commercial Physical & Biological Research8731
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Device Contract Manufacturing (CDMO)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Manufacturing Services
TypeProfessional Services
Description

ISO 13485-certified contract manufacturing for MedTech devices including precision manufacturing, global supply chain solutions, and medical plastics manufacturing. Revenue generated through manufacturing fees, design and engineering services, and regulatory compliance support.

sjmedtech.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Syrma Johari Medtech is an end-to-end MedTech contract manufacturing partner that designs, engineers, manufactures, and scales regulated medical devices for global original equipment manufacturers. Its offering spans concept-to-prototype design and engineering, ISO 13485-certified manufacturing across 16 production sites, integrated regulatory compliance (QARA) covering submissions and audits, and post-launch product lifecycle management, supported by proprietary technology platforms in microfluidics, optics, radiofrequency, ultrasound, electrotherapy, and microneedling.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 40%+ production cost savings for partners (e.g., Intelligent Bio Solutions partnership)
+3 more records
Product overview1 text field

Syrma Johari MedTech is an end-to-end MedTech solutions partner providing comprehensive services across the entire product lifecycle. The company operates a platform of integrated capabilities including Design & Engineering (concept-to-prototype development), Manufacturing (ISO 13485-certified production with 16 production sites), Compliance Services (QARA - regulatory submissions and audit readiness), and Product Lifecycle Management. The offering is structured around core technology platforms (Microfluidics, Optics and Photonics, Radiofrequency, Therapeutic Ultrasound, Electrotherapy, Microneedling) serving six market segments: Diagnostics, Medical Aesthetics, Patient Monitoring, Surgical & Interventional Care, Critical Care, and Rehabilitation & Physical Therapy. The company has 2.1 million square feet of manufacturing space across 16 production sites and 4 design centers, with manufacturing operations supporting FDA, ISO 13485, and MDSAP certifications.

Product and service4 records
1Design & Engineering
CategoryEngineering Services
Description

Concept-to-prototype medical device development service integrating system requirements, architecture, and full-stack engineering to ensure manufacturability, offered to global MedTech OEMs as a standalone engagement or part of an end-to-end manufacturing partnership.

2Medical Device Contract Manufacturing
CategoryManufacturing Services
Description

ISO 13485-certified contract manufacturing services including precision manufacturing, global supply chain solutions, and medical plastics manufacturing delivered across 16 production sites and 2.1 million square feet of manufacturing space for global MedTech OEMs.

3Compliance Services (QARA)
CategoryRegulatory Compliance Services
Description

Regulatory compliance and quality assurance service covering global submissions support, audit readiness, risk management, and post-market regulatory support for medical devices across FDA, ISO 13485, MDSAP, and GMP frameworks.

4Product Lifecycle Management
CategoryProduct Lifecycle Services
Description

Post-launch product lifecycle management service sustaining product viability through sustenance engineering, value analysis and value engineering (VAVE), and regulatory sustenance programs for MedTech OEMs across the full product lifecycle.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-31
Description

Strategic manufacturing partnership for Intelligent Fingerprinting Drug Screening Reader. Syrma Johari provides manufacturing capacity approximately 4x Intelligent Bio Solutions' current capability, with expected annual production cost savings exceeding 40% and gross margin improvement of approximately 20 percentage points. Partnership supports INBS planned US market entry in 2026 and strengthens supply chain resilience by reducing reliance on a single supplier. Readers are ISO 13485/MDSAP compliant. First shipment successfully received and deployed in February 2026.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership combining Hemex's proprietary fluorescence immunoassay (FIA) technology with Syrma Johari's assay development and optimization expertise. Collaboration aims to create diagnostic solutions for unmet needs across a range of diseases, particularly targeting chronic disease diagnostics in challenging markets through decentralized testing platforms.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Manufacturing partnership for Volk Optical's eye healthcare devices. Syrma Johari has been credited for exceptional dedication, attention to detail, and technical excellence in bringing optical medical devices to market. The partnership reflects collaborative approach and proactive communication.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Manufacturing partnership for Spinex medical devices. Product units built by Syrma Johari MedTech have been well received by patients with overwhelmingly positive feedback on design, build quality, and functionality, demonstrating Syrma Johari's commitment and technical excellence.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

European-headquartered medical device and pharmaceutical packaging manufacturer with growing CDMO capabilities. Comparable as a global manufacturer serving diagnostics and medical device OEMs with certified, multi-site production.

TypeDirect peer
Description

Pure-play medical device CDMO specializing in outsourced design, manufacturing, and regulatory support for medical devices and components. Closest pure-play peer to Syrma Johari given shared focus on regulated medical device outsourcing across multiple therapeutic areas.

TypeBroad incumbent
Description

Global EMS with a Medical segment providing integrated manufacturing solutions for medical devices, diagnostics, and imaging systems. Comparable as a multi-region partner offering design, manufacturing, and regulatory services for MedTech OEMs.

TypeDirect peer
Description

Medical device design and contract manufacturing business within Nordson, providing component and device manufacturing for interventional and surgical markets. Comparable in serving minimally-invasive and interventional device OEMs with regulatory-grade manufacturing.

TypeBroad incumbent
Description

Global EMS/CDMO with a dedicated Health Solutions business serving MedTech OEMs across diagnostics, surgical, and patient monitoring. Comparable as a large-scale, multi-region contract manufacturer offering design, manufacturing, and regulatory services to medical device customers.

TypeDirect peer
Description

Pure-play MedTech contract manufacturer offering design, engineering, and manufacturing services for medical devices including surgical, diagnostics, and therapeutic categories. Comparable in dedicated MedTech focus and integrated service offering.

TypeDirect peer
Description

Specialist MedTech-focused EMS/CDMO providing design, manufacturing, and aftermarket services to medical device OEMs. Comparable given its exclusive healthcare/life-sciences focus and end-to-end product lifecycle capabilities.

TypeBroad incumbent
Description

EMS provider with a Medical segment delivering complex medical device engineering and manufacturing. Comparable as a multi-region CDMO offering design support, manufacturing, and regulatory compliance for MedTech customers.

TypeBroad incumbent
Description

Global EMS with a Healthcare segment serving diagnostics, imaging, and medical device OEMs. Comparable in providing multi-region contract manufacturing for regulated medical products including diagnostic instrumentation.

TypeBroad incumbent
Description

Division of Jabil providing MedTech manufacturing, diagnostics, and drug-delivery device services. Directly comparable in offering end-to-end medical device contract manufacturing across diagnostics and surgical markets globally.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Syrma Johari Medtech Limited

Medical Device Contract Manufacturing (CDMO)syrmajoharimedtech.com

India-based end-to-end MedTech CDMO with 16 production sites and 4 design centers across India, the US, the EU, and the UK, providing ISO 13485-certified design, engineering, manufacturing, and regulatory services to global medical device OEMs across diagnostics, surgical, aesthetics, critical care, patient monitoring, and rehabilitation segments.

What Syrma Johari Medtech Limited does

Syrma Johari Medtech Limited is a privately held, India-headquartered end-to-end MedTech contract development and manufacturing organization (CDMO), founded around 1979–1980, that provides design, engineering, ISO 13485-certified manufacturing, and regulatory compliance services to global medical device OEMs. The company operates 16 production sites and 4 design and innovation centers spanning India, the United States, the European Union, and the United Kingdom, with 2.1 million square feet of total manufacturing space. Its technical platform spans six core technology areas—microfluidics, optics and photonics, radiofrequency, therapeutic ultrasound, electrotherapy, and microneedling—organized around six MedTech verticals: Diagnostics & IVD, Surgical & Interventional Care, Medical Aesthetics, Patient Monitoring, Critical Care, and Rehabilitation & Physical Therapy. Certifications across ISO 13485, MDSAP, FDA, and GMP, combined with integrated QARA capabilities, allow it to take OEM products from concept through scalable, multi-jurisdictional commercial production.

The company monetizes through B2B contract manufacturing fees, design and engineering services, and regulatory and lifecycle support, with quote-based pricing determined by product complexity, volume, and engagement scope. Its go-to-market is enterprise field sales targeting MedTech OEMs globally, supported by direct partnership models and regional manufacturing hubs. Named OEM partners include Hemex Health (point-of-care diagnostics), Volk Optical (endoscopic imaging), Spinex (medical devices), and Intelligent Bio Solutions, the latter representing the largest disclosed engagement: a strategic manufacturing partnership for the Intelligent Fingerprinting Drug Screening Reader that quadruples the customer's prior capacity, delivers more than 40% in annual production cost savings, and supports INBS's planned 2026 US market entry.

The company holds a string of recent industry recognitions—MedTech CDMO of the Year – Diagnostics and IVD (2026), Service Provider of the Year – Medical Supplies at the ET Healthcare Awards (2025), National Export Excellence Award (2024), and ET MSME Awards (2023)—and participates in India's PLI scheme for medical devices. There are no disclosed funding rounds, revenue figures, ownership percentages, or executive hires beyond the CEO, Suhas Tamras, in the available data.

Syrma Johari Medtech Limited firmographics

Firmographics
Name
Syrma Johari Medtech Limited
Legal name
Syrma Johari MedTech Ltd.
Website
https://syrmajoharimedtech.com
Company type
Private
Founded year
1980
Operating status
Operating
Headcount range
251–500 employees
Short description
India-based end-to-end MedTech CDMO with 16 production sites and 4 design centers across India, the US, the EU, and the UK, providing ISO 13485-certified design, engineering, manufacturing, and regulatory services to global medical device OEMs across diagnostics, surgical, aesthetics, critical care, patient monitoring, and rehabilitation segments.
Ownership category
akta.pro rank

Syrma Johari Medtech Limited industry classification

Industry
Product category
Medical Device Contract Manufacturing (CDMO)
NAICS
Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Scientific Research and Development Services (5417)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)
akta.pro secondary industry
Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent) (HLAGAKAO)

Keywords

  • Medical device manufacturing
  • Contract manufacturing services
  • Medtech design engineering
  • Regulatory compliance services
  • In vitro diagnostics manufacturing

Where Syrma Johari Medtech Limited is headquartered

Location

Headquarters

HQ city
Jodhpur
HQ country
India
HQ region
Asia

Offices3 records

Markets served

Syrma Johari Medtech Limited business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Contract Manufacturing Services: ISO 13485-certified contract manufacturing for MedTech devices including precision manufacturing, global supply chain solutions, and medical plastics manufacturing. Revenue generated through manufacturing fees, design and engineering services, and regulatory compliance support.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

Syrma Johari Medtech Limited product offering

Product offering

Core offering

Syrma Johari Medtech is an end-to-end MedTech contract manufacturing partner that designs, engineers, manufactures, and scales regulated medical devices for global original equipment manufacturers. Its offering spans concept-to-prototype design and engineering, ISO 13485-certified manufacturing across 16 production sites, integrated regulatory compliance (QARA) covering submissions and audits, and post-launch product lifecycle management, supported by proprietary technology platforms in microfluidics, optics, radiofrequency, ultrasound, electrotherapy, and microneedling.

Product overview

Syrma Johari MedTech is an end-to-end MedTech solutions partner providing comprehensive services across the entire product lifecycle. The company operates a platform of integrated capabilities including Design & Engineering (concept-to-prototype development), Manufacturing (ISO 13485-certified production with 16 production sites), Compliance Services (QARA - regulatory submissions and audit readiness), and Product Lifecycle Management. The offering is structured around core technology platforms (Microfluidics, Optics and Photonics, Radiofrequency, Therapeutic Ultrasound, Electrotherapy, Microneedling) serving six market segments: Diagnostics, Medical Aesthetics, Patient Monitoring, Surgical & Interventional Care, Critical Care, and Rehabilitation & Physical Therapy. The company has 2.1 million square feet of manufacturing space across 16 production sites and 4 design centers, with manufacturing operations supporting FDA, ISO 13485, and MDSAP certifications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Design & Engineering Concept-to-prototype medical device development service integrating system requirements, architecture, and full-stack engineering to ensure manufacturability, offered to global MedTech OEMs as a standalone engagement or part of an end-to-end manufacturing partnership.
  • Medical Device Contract Manufacturing ISO 13485-certified contract manufacturing services including precision manufacturing, global supply chain solutions, and medical plastics manufacturing delivered across 16 production sites and 2.1 million square feet of manufacturing space for global MedTech OEMs.
  • Compliance Services (QARA) Regulatory compliance and quality assurance service covering global submissions support, audit readiness, risk management, and post-market regulatory support for medical devices across FDA, ISO 13485, MDSAP, and GMP frameworks.
  • Product Lifecycle Management Post-launch product lifecycle management service sustaining product viability through sustenance engineering, value analysis and value engineering (VAVE), and regulatory sustenance programs for MedTech OEMs across the full product lifecycle.

Quantifiable outcome

  • 40%+ production cost savings for partners (e.g., Intelligent Bio Solutions partnership)
  • +3 more outcomes

Companies that use Syrma Johari Medtech Limited

Customer profile

Named customers4 records

Segments6 records

Ideal customer profiles2 records

Syrma Johari Medtech Limited technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature6 records

Syrma Johari Medtech Limited partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and supporting.

  • Intelligent Bio Solutions Inc.coreStrategic or Co-development Partner · 31 December 2025Strategic manufacturing partnership for Intelligent Fingerprinting Drug Screening Reader. Syrma Johari provides manufacturing capacity approximately 4x Intelligent Bio Solutions' current capability, with expected annual production cost savings exceeding 40% and gross margin improvement of approximately 20 percentage points. Partnership supports INBS planned US market entry in 2026 and strengthens supply chain resilience by reducing reliance on a single supplier. Readers are ISO 13485/MDSAP compliant. First shipment successfully received and deployed in February 2026.
  • Hemex HealthcoreStrategic or Co-development PartnerPartnership combining Hemex's proprietary fluorescence immunoassay (FIA) technology with Syrma Johari's assay development and optimization expertise. Collaboration aims to create diagnostic solutions for unmet needs across a range of diseases, particularly targeting chronic disease diagnostics in challenging markets through decentralized testing platforms.
  • Volk Optical Inc.supportingStrategic or Co-development PartnerManufacturing partnership for Volk Optical's eye healthcare devices. Syrma Johari has been credited for exceptional dedication, attention to detail, and technical excellence in bringing optical medical devices to market. The partnership reflects collaborative approach and proactive communication.
  • SpinexsupportingStrategic or Co-development PartnerManufacturing partnership for Spinex medical devices. Product units built by Syrma Johari MedTech have been well received by patients with overwhelmingly positive feedback on design, build quality, and functionality, demonstrating Syrma Johari's commitment and technical excellence.

Scale indicators8 records

Recent moves5 records

Expansion highlights6 records

Syrma Johari Medtech Limited competitors and assessment

Company assessment

Broad incumbents

  • Gerresheimer AG: European-headquartered medical device and pharmaceutical packaging manufacturer with growing CDMO capabilities. Comparable as a global manufacturer serving diagnostics and medical device OEMs with certified, multi-site production.
  • Sanmina Corporation: Global EMS with a Medical segment providing integrated manufacturing solutions for medical devices, diagnostics, and imaging systems. Comparable as a multi-region partner offering design, manufacturing, and regulatory services for MedTech OEMs.
  • Flex Ltd. (Flextronics): Global EMS/CDMO with a dedicated Health Solutions business serving MedTech OEMs across diagnostics, surgical, and patient monitoring. Comparable as a large-scale, multi-region contract manufacturer offering design, manufacturing, and regulatory services to medical device customers.
  • Benchmark Electronics: EMS provider with a Medical segment delivering complex medical device engineering and manufacturing. Comparable as a multi-region CDMO offering design support, manufacturing, and regulatory compliance for MedTech customers.
  • Celestica Inc. Global EMS with a Healthcare segment serving diagnostics, imaging, and medical device OEMs. Comparable in providing multi-region contract manufacturing for regulated medical products including diagnostic instrumentation.
  • Jabil Healthcare: Division of Jabil providing MedTech manufacturing, diagnostics, and drug-delivery device services. Directly comparable in offering end-to-end medical device contract manufacturing across diagnostics and surgical markets globally.

Direct peers

  • Integer Holdings Corporation: Pure-play medical device CDMO specializing in outsourced design, manufacturing, and regulatory support for medical devices and components. Closest pure-play peer to Syrma Johari given shared focus on regulated medical device outsourcing across multiple therapeutic areas.
  • Nordson Medical: Medical device design and contract manufacturing business within Nordson, providing component and device manufacturing for interventional and surgical markets. Comparable in serving minimally-invasive and interventional device OEMs with regulatory-grade manufacturing.
  • Viant Medical: Pure-play MedTech contract manufacturer offering design, engineering, and manufacturing services for medical devices including surgical, diagnostics, and therapeutic categories. Comparable in dedicated MedTech focus and integrated service offering.
  • Plexus Corp. Specialist MedTech-focused EMS/CDMO providing design, manufacturing, and aftermarket services to medical device OEMs. Comparable given its exclusive healthcare/life-sciences focus and end-to-end product lifecycle capabilities.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Syrma Johari Medtech Limited social profiles

Digital presence

Syrma Johari Medtech Limited compliance and trust

Trust signal

Compliance4 records

Syrma Johari Medtech Limited financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Syrma Johari Medtech Limited leadership team

Management profile

Number of profiles

Profiles1 record

Syrma Johari Medtech Limited funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Syrma Johari Medtech Limited M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Syrma Johari Medtech Limited

What does Syrma Johari Medtech Limited do?

Syrma Johari Medtech is an end-to-end MedTech contract manufacturing partner that designs, engineers, manufactures, and scales regulated medical devices for global original equipment manufacturers. Its offering spans concept-to-prototype design and engineering, ISO 13485-certified manufacturing across 16 production sites, integrated regulatory compliance (QARA) covering submissions and audits, and post-launch product lifecycle management, supported by proprietary technology platforms in microfluidics, optics, radiofrequency, ultrasound, electrotherapy, and microneedling.

Is Syrma Johari Medtech Limited a public or private company?

Syrma Johari Medtech Limited is a private company. It is classified as unknown and is currently operating.

When was Syrma Johari Medtech Limited founded?

Syrma Johari Medtech Limited was founded in 1980. It employs 251 to 500 people.

Where is Syrma Johari Medtech Limited based?

Syrma Johari Medtech Limited is headquartered in Jodhpur, India, in the Asia region.

How does Syrma Johari Medtech Limited make money?

One revenue line is on record: contract Manufacturing Services.

Who are Syrma Johari Medtech Limited's main competitors?

Broad incumbents on record are Gerresheimer AG, Sanmina Corporation, Flex Ltd. (Flextronics), Benchmark Electronics, Celestica Inc. and Jabil Healthcare. Direct peers are Integer Holdings Corporation, Nordson Medical, Viant Medical and Plexus Corp..

Does Syrma Johari Medtech Limited have an API?

No public API is recorded for Syrma Johari Medtech Limited.

What industry is Syrma Johari Medtech Limited in?

Syrma Johari Medtech Limited's product category is Medical Device Contract Manufacturing (CDMO). Its primary akta.pro industry code is HLAGAKAL, Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control), with a secondary code of HLAGAKAO, Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical BuyerSJML launches 1.29 lakh sq. ft. medical plastics and precision molding facilitySyrma Johari MedTech Ltd launched a 1.29 lakh sq. ft. medical plastics and precision molding facility, adding injection molding, extrusion, and stretch blow molding. The facility includes ISO Class 7 and 8 cleanrooms and supports medical polymer components, with 0.31 lakh sq. ft. reserved for future expansion.Business StandardSyrma inaugurates new medical plastics and precision molding facility in JodhpurSyrma Johari MedTech inaugurated a new Medical Plastics and Precision Molding Facility in Jodhpur, Rajasthan. The 120,000+ sq ft plant covers injection molding, extrusion, blow molding, and tooling for precision medical components. It strengthens the Syrma SGS Group's manufacturing ecosystem with 17 global sites and four design centers.BioSpaceIntelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge GrowthIntelligent Bio Solutions reported fiscal 2026 revenue of $4.2 million, up 38% year-over-year, with gross profit margin expanding to 48.63%. The company's reader installed base grew 22% to 1,886 units, and consumable cartridges increased 35% to 106,500 units. It is on track for FDA submission in the second half of calendar 2026.Investing.comINBS partners with Syrma Johari to boost production, improve margins By Investing.comIntelligent Bio Solutions Inc. (NASDAQ:INBS) announced a strategic manufacturing partnership with Syrma Johari MedTech Ltd. to scale production of its Intelligent Fingerprinting Drug Screening Reader, with the collaboration expected to deliver annual production cost savings exceeding 40% and an improvement of approximately 20 percentage points in gross margin compared to previous manufacturing arrangements. Syrma Johari's manufacturing capacity is approximately four times INBS' current capacity, operating 14 manufacturing locations and four design centers across India, Europe, and the United States with ISO 13485, MDSAP, FDA, and GMP certifications. The partnership is designed to support INBS' planned U.S. market entry in 2026 while reducing reliance on a single supplier and building greater supply chain resilience.SyrmajoharimedtechContract Manufacturing of Medical Devices: A Regulatory-First GuideThe article outlines a regulatory-first framework for medical device Original Equipment Manufacturers (OEMs) to manage compliance risks when outsourcing production to Contract Manufacturing Organizations (CMOs). It emphasizes that OEMs retain full legal liability for safety and quality, requiring rigorous supplier controls, audits, and documentation aligned with global regulations such as FDA, EU MDR, and CDSCO. A case study of an FDA warning letter illustrates the severe consequences of inadequate oversight, while highlighting Syrma Johari MedTech as a compliant partner.